Ondo Finance introduced Ondo Private Markets, offering tokenized notes that track the value of private pre-IPO companies without granting equity or voting rights. The first offering is linked to an undisclosed AI firm and is issued by a British Virgin Islands entity, allowing qualified non-US investors to participate under SEC Regulation S. These notes trade 24/7 on blockchain, with returns tied to liquidity events like IPOs or acquisitions. Ondo plans to expand offerings into other sectors such as robotics and biotech in the coming months.
Ondo Finance's launch of a blockchain-based private company investment platform provides context for digital asset market activity. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 07, 2026 01:12 WIB: among 50 major cryptocurrencies, 24 rose and 25 fell today. Notable movers include UNI (Uniswap) at Rp154.755 with a 1-day change of -3.26%, SAND (The Sandbox) at Rp1.170 down 3.16%, and ADA (Cardano) at Rp4.877 up 2.93%.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
